PetMed Express, Inc. (PETS)
NASDAQ·Healthcare·Medical - Pharmaceuticals
$2.27
-1.31%
Mkt Cap $55.43M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 5, 2026 | $54.04M | $40.66M | -24.77% | -$0.06 | -$0.50 | -733.33% | — | — |
| Q4 2025 Dec 19, 2025 | $69.31M | $44.36M | -35.99% | -$0.02 | -$0.34 | -1600.00% | — | — |
| Q1 2025 Feb 10, 2025 | $54.00M | $52.98M | -1.88% | $0.01 | -$0.03 | -700.00% | — | — |
| Q4 2024 Nov 6, 2024 | $66.00M | $59.57M | -9.74% | -$0.05 | $0.11 | +320.00% | — | — |
| Q3 2024 Aug 6, 2024 | $75.00M | $67.95M | -9.40% | -$0.09 | $0.18 | +300.00% | — | — |
| Q2 2024 Apr 15, 2024 | $65.00M | $66.50M | +2.31% | -$0.01 | -$0.10 | -900.00% | — | — |
| Q1 2024 Feb 8, 2024 | $65.00M | $65.32M | +0.49% | -$0.01 | -$0.10 | -900.00% | — | — |
| Q4 2023 Oct 30, 2023 | $76.00M | $71.00M | -6.58% | $0.09 | -$0.00 | -103.81% | — | — |
| Q3 2023 Jul 31, 2023 | $79.44M | $78.24M | -1.51% | $0.07 | -$0.04 | -157.14% | — | — |
| Q2 2023 May 22, 2023 | $65.90M | $62.41M | -5.30% | $0.15 | $0.04 | -73.33% | — | — |
| Q1 2023 Feb 6, 2023 | $62.03M | $58.87M | -5.10% | $0.20 | $0.02 | -90.00% | — | — |
| Q4 2022 Nov 7, 2022 | $65.40M | $65.39M | -0.01% | $0.25 | $0.13 | -48.00% | — | — |
| Q3 2022 Jul 25, 2022 | $78.25M | $70.19M | -10.31% | $0.25 | $0.14 | -44.00% | — | — |
| Q2 2022 May 9, 2022 | $68.25M | $66.00M | -3.30% | $0.26 | $0.30 | +15.38% | — | — |
| Q1 2022 Jan 24, 2022 | $64.11M | $60.72M | -5.30% | $0.30 | $0.21 | -30.00% | — | — |
| Q4 2021 Oct 25, 2021 | $75.72M | $67.39M | -11.01% | $0.35 | $0.31 | -11.43% | — | — |
| Q3 2021 Jul 26, 2021 | $75.71M | $79.31M | +4.76% | $0.35 | $0.26 | -25.71% | — | — |
| Q2 2021 May 3, 2021 | $74.04M | $71.68M | -3.19% | $0.40 | $0.34 | -15.00% | — | — |
| Q1 2021 Jan 19, 2021 | $63.81M | $65.90M | +3.27% | $0.38 | $0.38 | +0.00% | — | — |
| Q4 2020 Oct 26, 2020 | $71.84M | $75.44M | +5.00% | $0.40 | $0.42 | +5.00% | — | — |